CURX — Curanex Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $22.11m
- $22.40m
Annual cashflow statement for Curanex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.02 | -0.019 |
| Non-Cash Items | 0.021 | 0.002 |
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.002 | 0.017 |
| Change in Inventories | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | 0.003 | -0 |
| Financing Cash Flow Items | -0.003 | 0.072 |
| Other Financing Cash Flow | ||
| Cash from Financing Activities | -0.003 | 0.072 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0 | 0.072 |